Encyclopedia of Signaling Molecules

2012 Edition
| Editors: Sangdun Choi

Estrogen Receptor

  • Karin Dahlman-Wright
  • Chunyan Zhao
Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-0461-4_241

Synonyms

Historical Background

In 1896, physician George Beatson observed that removal of the ovaries caused regression of mammary tumors in women. His experiments were the first to establish a link between ovarian secretions and breast cancer. Later in the early 1930s, the “female” sex hormones, estrone and estriol, could be isolated from human pregnancy urine, followed by isolation of a third estrogen, estradiol (E2), from pig follicular fluid. Shortly thereafter, a number of estrogenic compounds were synthesized and used therapeutically, but the mechanisms of estrogen action remained obscure. However, in 1958 Elwood Jensen produced a major breakthrough when he used a radioactive marker to demonstrate that only estrogen-responsive tissues were able to concentrate injected estrogen from the blood, suggesting the existence of estrogen-binding components, which were called “estrogen receptors (ERs).” Further...

This is a preview of subscription content, log in to check access.

References

  1. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol. 2006;20:1707–14.PubMedCrossRefGoogle Scholar
  2. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38:1289–97.PubMedCrossRefGoogle Scholar
  3. Cloonan N, Forrest AR, Kolle G, Gardiner BB, Faulkner GJ, Brown MK, et al. Stem cell transcriptome profiling via massive-scale mRNA sequencing. Nat Meth. 2008;5:613–9.CrossRefGoogle Scholar
  4. Dahlman-Wright K, Cavailles V, Fuqua SA, Jordan VC, Katzenellenbogen JA, Korach KS, et al. International union of pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006;58:773–81.PubMedCrossRefGoogle Scholar
  5. Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, et al. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 2010;24:709–21.PubMedCrossRefGoogle Scholar
  6. Kininis M, Kraus WL. A global view of transcriptional regulation by nuclear receptors: gene expression, factor localization, and DNA sequence analysis. Nucl Recept Signal. 2008;6:e005.PubMedGoogle Scholar
  7. Kininis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, et al. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol Cell Biol. 2007;27:5090–104.PubMedCrossRefGoogle Scholar
  8. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996;93:5925–30.PubMedCrossRefGoogle Scholar
  9. Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation. Endocr Relat Cancer. 2005;12(Suppl 1):75–84.CrossRefGoogle Scholar
  10. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281–92.PubMedCrossRefGoogle Scholar
  11. O’Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004;18:1859–75.PubMedCrossRefGoogle Scholar
  12. Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11:643–58.PubMedCrossRefGoogle Scholar
  13. Spears M, Bartlett J. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opin Ther Targets. 2009;13:665–74.PubMedCrossRefGoogle Scholar
  14. Welboren WJ, Stunnenberg HG, Sweep FC, Span PN. Identifying estrogen receptor target genes. Mol Oncol. 2007;1:138–43.PubMedCrossRefGoogle Scholar
  15. Williams C, Edvardsson K, Lewandowski SA, Strom A, Gustafsson JA. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 2008;27:1019–32.PubMedCrossRefGoogle Scholar
  16. Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, et al. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene. 2003;22:7600–6.PubMedCrossRefGoogle Scholar
  17. Zhao C, Dahlman-Wright K, Gustafsson JA. Estrogen receptor beta: an overview and update. Nucl Recept Signal. 2008;6:e003.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Biosciences and NutritionNovum, Karolinska InstitutetHuddingeSweden